日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways.

BCL2 通过协调致癌通路之间的相互串扰,驱动去势敏感性前列腺癌产生去势抵抗

Hirani Rahim, Nandakumar Subhiksha, Zaman Nabila, Prabhakaraalva Prathiksha, King Sarah Ann, Kalidindi Teja Muralidhar, Ghale Romina, Rajanala Sai Harisha, Fidele Deborah C, De Stanchina Elisa, Mary Lee Gwo-Shu, Taplin Mary Ellen, Balk Steven P, Sowalsky Adam G, Morris Michael J, Kishore Pillarsetty Naga Vara, Stopsack Konrad H, Gopalan Anuradha, Mucci Lorelei A, Kyprianou Natasha, Tewari Ashutosh K, Danila Daniel, Kantoff Philip W, Chakraborty Goutam

A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genes

一项针对转移性去势抵抗性前列腺癌且无DNA损伤反应基因突变患者的1b/2期研究,评估间歇性使用他拉唑帕尼联合替莫唑胺的疗效。

Autio, Karen A; Kyriakopoulos, Christos E; Palyca, Paul; Xiao, Han; Emamekhoo, Hamid; Danila, Daniel; Jan, Mehrin; Catharine, Victoria; Riedel, Elyn; Devitt, Michael; Laird, A Douglas; Scher, Howard I

Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study

Xaluritamig,一种针对转移性去势抵抗性前列腺癌的STEAP1 × CD3 XmAb 2+1免疫疗法:首次人体试验剂量探索结果

Kelly, William K; Danila, Daniel C; Lin, Chia-Chi; Lee, Jae-Lyun; Matsubara, Nobuaki; Ward, Patrick J; Armstrong, Andrew J; Pook, David; Kim, Miso; Dorff, Tanya B; Fischer, Stefanie; Lin, Yung-Chang; Horvath, Lisa G; Sumey, Christopher; Yang, Zhao; Jurida, Gabor; Smith, Kristen M; Connarn, Jamie N; Penny, Hweixian L; Stieglmaier, Julia; Appleman, Leonard J

The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide

循环肿瘤细胞 HOXB13 RNA 检测对接受阿比特龙或恩扎卢胺治疗的转移性去势抵抗性前列腺癌 (mCRPC) 患者的影响

Halabi, Susan; Guo, Siyuan; Park, Joseph J; Nanus, David M; George, Daniel J; Antonarakis, Emmanuel S; Danila, Daniel Costin; Szmulewitz, Russell Zelig; McDonnell, Donald P; Norris, John D; Lu, Changxue; Luo, Jun; Armstrong, Andrew J

Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

前列腺癌患者的微卫星不稳定性、肿瘤突变负荷和免疫检查点阻断疗法反应

Lenis, Andrew T; Ravichandran, Vignesh; Brown, Samantha; Alam, Syed M; Katims, Andrew; Truong, Hong; Reisz, Peter A; Vasselman, Samantha; Nweji, Barbara; Autio, Karen A; Morris, Michael J; Slovin, Susan F; Rathkopf, Dana; Danila, Daniel; Woo, Sungmin; Vargas, Hebert A; Laudone, Vincent P; Ehdaie, Behfar; Reuter, Victor; Arcila, Maria; Berger, Michael F; Viale, Agnes; Scher, Howard I; Schultz, Nikolaus; Gopalan, Anuradha; Donoghue, Mark T A; Ostrovnaya, Irina; Stopsack, Konrad H; Solit, David B; Abida, Wassim

PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer

PSMA阳性循环肿瘤细胞检测及转移性去势抵抗性前列腺癌患者接受阿比特龙或恩扎卢胺治疗的预后

Gupta, Santosh; Halabi, Susan; Yang, Qian; Roy, Akash; Tubbs, Alisa; Gore, Yamini; George, Daniel J; Nanus, David M; Antonarakis, Emmanuel S; Danila, Daniel C; Szmulewitz, Russell Z; Wenstrup, Richard; Armstrong, Andrew J

Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients

快速基因检测模式对晚期前列腺癌患者的临床影响

Breen, Kelsey E; Symecko, Heather; Spielman, Kelsey; Gebert, Rebecca; Shah, Ibrahim H; Pundock, Stacy; Batson, Melissa; Narayan, Vivek K; Stadler, Zsofia K; Autio, Karen A; Abida, Wassim; Danila, Daniel C; Scher, Howard I; Morris, Michael J; Hamilton, Jada G; Robson, Mark E; Domchek, Susan M; Carlo, Maria I

Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings

癌症相关巨噬细胞样细胞在非转移性和转移性前列腺癌中均具有预后价值。

Gironda, Daniel J; Bergan, Raymond C; Alpaugh, R Katherine; Danila, Daniel C; Chuang, Tuan L; Hurtado, Brenda Y; Ho, Thai; Adams, Daniel L

Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer

在伊匹木单抗治疗激素敏感性前列腺癌的II期研究中,使用PRO-CTCAE评估免疫相关不良事件

de Almeida, Daniel Vargas P; Anderson, Justine M; Danila, Daniel C; Morris, Michael J; Slovin, Susan F; Abida, Wassim; Cohn, Erica D; Baser, Raymond E; Scher, Howard I; Autio, Karen A

Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects

GALAHAD研究中与健康相关的生活质量:一项针对转移性去势抵抗性前列腺癌伴DNA修复基因缺陷患者的尼拉帕尼多中心、开放标签II期研究

Smith, Matthew R; Sandhu, Shahneen; George, Daniel J; Chi, Kim Nguyen; Saad, Fred; Thiery-Vuillemin, Antoine; Stàhl, Olaf; Olmos, David; Danila, Daniel C; Gafanov, Rustem; Castro, Elena; Moon, Helen; Joshua, Anthony M; Mason, Gary E; Espina, Byron M; Liu, Yan; Lopez-Gitlitz, Angela; Francis, Peter; Bevans, Katherine B; Fizazi, Karim